Clinical Trials Sponsored by Janssen Pharmaceutica

Total 22188 results

Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

Healthy

Taiwan
Xian-Janssen Pharmaceutical Ltd.

Completed

An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome

Myelodysplastic Syndrome

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

Schizophrenia

China
Xian-Janssen Pharmaceutical Ltd.

Completed

Efficacy and Safety Study of Loperamide Hydrochloride/Simethicone Chewable Tablet in Treatment of Acute Diarrhea With Abdominal Discomfort and Flatulence

Diarrhea

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Psoriasis

China
Xian-Janssen Pharmaceutical Ltd.

Completed

An Observational Study of Chinese Multiple Myeloma Patients Treated With Velcade

Multiple Myeloma
Xian-Janssen Pharmaceutical Ltd.

Terminated

An Observational Study to Evaluate Efficacy and Safety of Risperidone Long-Acting Injection for Treatment of Schizophrenia

Schizophrenia
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back Pain

Low Back Pain | Neck Pain | Shoulder Pain
Xian-Janssen Pharmaceutical Ltd.

Completed

A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia

Schizophrenia

China
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections

Pulmonary Fungal Infection
Xian-Janssen Pharmaceutical Ltd.

Active, not recruiting

A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

Crohn Disease

China
Xian-Janssen Pharmaceutical Ltd.

Completed

Preliminarily Evaluate the Efficacy of Domperidone in Adult Chinese Participants With Functional Dyspepsia

Dyspepsia

China
Xian-Janssen Pharmaceutical Ltd.

Completed

Study of Bortezomib (BTZ) Treatment on Mantle Cell Lymphoma (MCL) in Chinese Participants

Lymphoma, Mantle-Cell

China
Xian-Janssen Pharmaceutical Ltd.

Completed

Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation

Constipation

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants

Attention Deficit Hyperactivity Disorder (ADHD)

China
Xian-Janssen Pharmaceutical Ltd.

Completed

An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

Congestive Heart Failure | Heart Decompensation

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Comparative Efficacy and Safety Study of Compound Carraghenates Cream With Mayinglong Musk Hemorrhoid Ointment in the Treatment of Hemorrhoids

Hemorrhoids
Xian-Janssen Pharmaceutical Ltd.

Completed

A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy Volunteers

Healthy
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Schizophrenia
Xian-Janssen Pharmaceutical Ltd.

Completed

A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of Schizophrenia

Acute Schizophrenia

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Alzheimer Disease
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

Healthy

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Advanced or Metastatic Liposarcoma or Leiomyosarcoma

China
Xian-Janssen Pharmaceutical Ltd.

Withdrawn

Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy Participants

Healthy

China
Janssen Pharmaceutical K.K.
GlaxoSmithKline

Completed

A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine

Arthritis, Rheumatoid

Japan
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom

Depressive Disorder, Major

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia

Schizophrenia

China
Xian-Janssen Pharmaceutical Ltd.

Terminated

A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Epithelial Ovarian Cancer

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis

Ulcerative Colitis

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Pharmacokinetic and Safety Study of Osmotic Release Oral System (OROS) Hydromorphone in Non-Opioid Tolerant Chinese Participants With Cancer

Pain

China
Xian-Janssen Pharmaceutical Ltd.

Completed

A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression

Major Depressive Disorder

China
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis

Arthritis, Rheumatoid
Xian-Janssen Pharmaceutical Ltd.

Completed

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Pharmacokinetics
Johnson & Johnson Pharmaceutical Research & Development...
Janssen Pharmaceutica N.V., Belgium

Completed

A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.

Neoplasms | Lymphoma

United Kingdom
Johnson & Johnson Pharmaceutical Research & Development...
Janssen Pharmaceutica N.V., Belgium

Completed

A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.

Pharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
Duke University
Janssen Pharmaceuticals

Completed

Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer

Prostate Cancer

United States
Columbia University
Janssen Pharmaceuticals

Recruiting

Tumor Microenvironment Analysis of Prostate Cancer Metastasis

Recurrent Prostate Cancer

United States
Pharmacyclics LLC.
Janssen Pharmaceuticals

Completed

Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) (PCYC-1104-CA)

Mantle Cell Lymphoma

United States, United Kingdom, Germany, Poland
Duke University
Janssen Pharmaceuticals

Completed

Risperidone Augmentation for PTSD

Post-Traumatic Stress Disorder

United States
ViiV Healthcare
Janssen Pharmaceuticals

Completed

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

HIV Infections

Germany, Netherlands, France, Belgium, Spain
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Analyze the Impact of Treatment With Paliperidone Palmitate on Clinical Outcomes and Hospital Resource Utilization in Adult Participants With Schizophrenia in Portugal (PsiProsper)

Schizophrenia

Portugal
Janssen-Cilag Farmaceutica Ltda.

Approved for marketing

Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

B-cell Chronic Lymphocytic Leukemia

Brazil
Janssen-Cilag Farmaceutica Ltda.

Completed

An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol

Contraception

Brazil, Mexico
Janssen-Cilag Farmaceutica Ltda.

Completed

An Efficacy and Tolerability Study for Topiramate in Obese Patients With Binge Eating Disorder.

Binge Eating
Nantes University Hospital
Janssen Pharmaceutica

Not yet recruiting

Minimal Residual Disease-based Strategy With T-Cell Redirector After Treatment With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma (IFm2022-01)

Multiple Myeloma

France
European Myeloma Network
Janssen Pharmaceutica

Active, not recruiting

A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

Light Chain (AL) Amyloidosis, Stage 3B

Netherlands, Greece, France, Italy
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Alzheimer Disease
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

Epilepsy | Seizures
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

Migraine Disorders
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal

3

Subscribe